Analysts See $-0.80 EPS for Uniqure NV (QURE); Mannatech (MTEX) SI Increased By 7.86%

October 28, 2017 - By Kurt Siggers

Analysts expect Uniqure NV (NASDAQ:QURE) to report $-0.80 EPS on November, 28.They anticipate $0.20 EPS change or 33.33% from last quarter’s $-0.6 EPS. After having $-0.83 EPS previously, Uniqure NV’s analysts see -3.61% EPS growth. The stock decreased 2.04% or $0.32 on October 27, reaching $15.38. About 682,255 shares traded. Uniqure NV (NASDAQ:QURE) has declined 52.65% since October 28, 2016 and is downtrending. It has underperformed by 69.35% the S&P500.

Mannatech (NASDAQ:MTEX) had an increase of 7.86% in short interest. MTEX’s SI was 15,100 shares in October as released by FINRA. Its up 7.86% from 14,000 shares previously. With 1,400 avg volume, 11 days are for Mannatech (NASDAQ:MTEX)’s short sellers to cover MTEX’s short positions. The SI to Mannatech’s float is 0.99%. The stock increased 2.08% or $0.3 on October 27, reaching $14.7. About 742 shares traded. Mannatech, Inc. (NASDAQ:MTEX) has declined 28.68% since October 28, 2016 and is downtrending. It has underperformed by 45.38% the S&P500.

Among 12 analysts covering uniQure N.V. (NASDAQ:QURE), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. uniQure N.V. had 25 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, November 22, the company rating was downgraded by Jefferies. The rating was initiated by WallachBeth Capital with “Buy” on Friday, August 7. The rating was maintained by Chardan Capital Markets with “Buy” on Thursday, August 27. The firm has “Neutral” rating by PiperJaffray given on Wednesday, November 16. Oppenheimer maintained the shares of QURE in report on Monday, September 21 with “Outperform” rating. Janney Capital initiated Uniqure NV (NASDAQ:QURE) rating on Tuesday, December 1. Janney Capital has “Buy” rating and $40 target. The company was maintained on Friday, August 28 by WallachBeth Capital. The firm earned “Buy” rating on Tuesday, September 1 by Zacks. The company was maintained on Wednesday, July 12 by Cowen & Co. The firm has “Buy” rating by Chardan Capital Markets given on Thursday, October 1.

Uniqure NV is a gene therapy company based in the Netherlands. The company has market cap of $394.18 million. The Firm is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. It currently has negative earnings. The Firm advances a focused pipeline of gene therapies that are developed both internally and through partnerships.

Mannatech, Incorporated is a wellness solution provider. The company has market cap of $39.86 million. The Firm develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products. It has a 96.63 P/E ratio. The Firm operates through the segment of sale of nutritional supplements, skin care and anti-aging products, and weight management and fitness products through network marketing distribution channels in approximately 20 countries.